23y | 1.6y Minoxidil & Biotine + 1y Finasteride + Keto | 7m Microneedling (stopped) | Progress & Temples? 9/23/2025
A 23-year-old has been using minoxidil for 1.6 years, finasteride for 1 year, and ketoconazole shampoo, along with biotin, to treat hair loss. They noticed baby hairs and a fuller hairline but seek further improvement, especially in the temple areas, and are considering adding rosemary oil and a dermastamp.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 23y | 1.7y Minoxidil & Biotine + 1.1y Finasteride + Keto | 7m of 1mm Microneedling (stopped) | Progress & Temples?
A user shared their hair loss progress using minoxidil, biotin, finasteride, and ketoconazole, with 7 months of microneedling. They confirmed using oral treatments.
community Is bad? - 23y | 1.7y Minoxidil & Biotine + 1.1y Finasteride + Keto | 8m Microneedling (stopped) | Progress & Temples?
The conversation discusses hair regrowth progress using Minoxidil, Biotin, Finasteride, and Ketoconazole, with microneedling stopped after 8 months. The user is questioning the effectiveness on temple areas after 1.7 years of treatment.
community Other than Finasteride, Minoxidil, Nizoral and Microneedling. What else do you do?
People discuss various hair loss treatments, including finasteride, minoxidil, ketoconazole shampoo, biotin, vitamins, tretinoin cream, laser caps, and lifestyle changes like quitting smoking. They also mention using products like nutrafol, pumpkin seed oil, fish oil, and scalp massages.
community Microneedling + topical fin/min: how to structure the routine?
The user is using a topical spray containing finasteride, minoxidil, ketoconazole, and biotin for hair loss and plans to add weekly dermastamping, starting with a needle length of 0.6mm. They seek advice on the safety of combining these treatments, the impact of skipping one dose weekly, and the frequency of replacing the dermastamp.
community 4 years of Miioxidil and Finasteride, added Microneedling am I regrowing or what I should do more?
The user has been using Minoxidil, Finasteride, and biotin for hair regrowth over four years, recently adding microneedling with a derma pen. They are considering increasing microneedling frequency, trying minoxidil pills, and possibly using Dutasteride for better results.
Related Research
6 / 6 resultsresearch A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
research Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
This review discusses treatment options for androgenetic alopecia, highlighting the need for personalized, evidence-based approaches but reports no new clinical results.
research Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
This review examines androgenetic alopecia, detailing its causes and current treatments, but reports no new clinical results; the authors emphasize understanding its complexity for personalized therapy development.
research Male androgenetic alopecia
This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.
research Hair Restoration in Androgenetic Alopecia: Looking Beyond Minoxidil, Finasteride and Hair Transplantation
This review discusses the emerging pathophysiological factors and potential new therapies for androgenetic alopecia beyond traditional treatments, but reports no new results.
research Pathogenic Mechanisms and Mechanism‐Directed Therapies for Androgenetic Alopecia: Current Understanding and Future Directions
In this review, researchers explored key mechanisms underlying androgenetic alopecia, revealing how hormonal, oxidative, inflammatory, and lipid dysregulation suppress hair growth pathways and suggesting new therapeutic targets such as DP2 antagonists and microbiome modulators.